EZH2 and breast carcinoma: MLL1, G9a, SUV39H1, JMJD3, and EZH2 expressions are increased in glioblastoma multiforme, breast cancer cell, and human fetal lung epithelial cells under hypoxic microenvironment, respectively29–33.